Cargando…

Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents

Diabetes mellitus is a chronic multifaceted disease with multiple potential complications, the treatment of which can only delay and prolong the terminal stage of the disease, i.e., type 2 diabetes mellitus (T2DM). The World Health Organization predicts that diabetes will be the seventh leading caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Jingqian, Luo, Yingsheng, Hu, Shan, Tang, Lu, Ouyang, Songying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487533/ https://www.ncbi.nlm.nih.gov/pubmed/37686185 http://dx.doi.org/10.3390/ijms241713381

Ejemplares similares

Progress in Research on the Alleviation of Glucose Metabolism Disorders in Type 2 Diabetes Using Cyclocarya paliurus
por: Wang, Xue, et al.
Publicado: (2022)

Research Progress on the Anti-Aging Potential of the Active Components of Ginseng
por: Su, Jingqian, et al.
Publicado: (2023)

The Pathogenesis of Sepsis and Potential Therapeutic Targets
por: Huang, Min, et al.
Publicado: (2019)

Regulation of cGAS‐Mediated Immune Responses and Immunotherapy
por: Saeed, Abdullah F. U. H., et al.
Publicado: (2020)

Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect
por: Xia, En-Qin, et al.
Publicado: (2017)

Current therapeutic agents and anesthetic considerations for diabetes mellitus
por: Kang, Hyoseok
Publicado: (2012)

A Novel Therapeutic Agent for Type 2 Diabetes Mellitus: SGLT2 Inhibitor
por: Jung, Chang Hee, et al.
Publicado: (2014)

Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related Diseases
por: Guan, Biyun, et al.
Publicado: (2022)

The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages
por: Yu, Yun, et al.
Publicado: (2020)

Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus
por: Zu, Guoxiu, et al.
Publicado: (2021)

Functional Features and Current Applications of the RNA‐Targeting Type VI CRISPR‐Cas Systems
por: Perčulija, Vanja, et al.
Publicado: (2021)

Epigenetic modification and therapeutic targets of diabetes mellitus
por: Singh, Rajveer, et al.
Publicado: (2020)

Metabolome and Whole-Transcriptome Analyses Reveal the Molecular Mechanisms Underlying Hypoglycemic Nutrient Metabolites Biosynthesis in Cyclocarya paliurus Leaves During Different Harvest Stages
por: Zheng, Xuehai, et al.
Publicado: (2022)

Research Advances and Detection Methodologies for Microbe-Derived Acetylcholinesterase Inhibitors: A Systemic Review
por: Su, Jingqian, et al.
Publicado: (2017)

Changes of Blink Reflex in Type 2 Diabetes Mellitus
por: Xiao, Li, et al.
Publicado: (2021)

Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus
por: Huang, Mingshu, et al.
Publicado: (2023)

Adipokines: Potential Therapeutic Targets for Vascular Dysfunction in Type II Diabetes Mellitus and Obesity
por: El husseny, Mostafa Wanees Ahmed, et al.
Publicado: (2017)

Novel targets for potential therapeutic use in Diabetes mellitus
por: Dhankhar, Sanchit, et al.
Publicado: (2023)

Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications
por: Zhang, Jing, et al.
Publicado: (2022)

An update on diagnosis and therapeutics for type-2 diabetes mellitus
por: Shyamaladevi, Babu, et al.
Publicado: (2023)

Fucoxanthin Ameliorates Sepsis via Modulating Microbiota by Targeting IRF3 Activation
por: Su, Jingqian, et al.
Publicado: (2023)

Association of body mass index and fasting plasma glucose concentration with post-transplantation diabetes mellitus in Chinese heart transplant recipients
por: Zhao, Tian, et al.
Publicado: (2020)

Recent advances in targeted protein degraders as potential therapeutic agents
por: Yang, Na, et al.
Publicado: (2023)

Research advances in gestational, neonatal diabetes mellitus and metabolic disorders
por: Bukhari, Ihtisham, et al.
Publicado: (2022)

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
por: Ikeda, Masayuki, et al.
Publicado: (2019)

Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus
por: Roham, Pratiksha H., et al.
Publicado: (2022)

Short-Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2
por: Neag, Maria-Adriana, et al.
Publicado: (2022)

Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus
por: Hu, Ying
Publicado: (2019)

Research progress on alternative kombucha substrate transformation and the resulting active components
por: Su, Jingqian, et al.
Publicado: (2023)

Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity
por: Oh, Chang-Myung, et al.
Publicado: (2016)

The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
por: Dewanjee, Saikat, et al.
Publicado: (2021)

Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus
por: Islam, Fahadul, et al.
Publicado: (2022)

Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus
por: You, SuFang, et al.
Publicado: (2022)

Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus
por: Ansari, Prawej, et al.
Publicado: (2022)

Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice
por: Shah, Najeeb, et al.
Publicado: (2021)

Analysis of Communal Molecular Mechanism and Potential Therapeutic Targets in Heart Failure and Type 2 Diabetes Mellitus
por: Wang, Zuoxiang, et al.
Publicado: (2021)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
por: Hamzé, Rim, et al.
Publicado: (2022)

The complex pathophysiology of bone fragility in obesity and type 2 diabetes mellitus: therapeutic targets to promote osteogenesis
por: Bathina, Siresha, et al.
Publicado: (2023)

Efferocytosis: An Emerging Therapeutic Strategy for Type 2 Diabetes Mellitus and Diabetes Complications
por: Liu, Xun, et al.
Publicado: (2023)

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
por: Moon, Min Kyong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gdp0h3v76neno47hmoupome205